The Effects of Two Different Treatment Protocols on Shoulder Function, Quality of Life, and Ultrasound Parameters in Patients With Frozen Shoulder

NCT ID: NCT05956171

Last Updated: 2023-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-01

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this interventional study is to compare the outcomes of two different injection aprroaches in patients with frozen shoulder. The main questions it aims to answer are:

* Is hydrodilatation better than intraarticular corticosteroid injection?
* Is there any prognostic factors that will help clinicians guide their decision making when choosing between these two treatments?

Participans will receive an injection(cortcosteroid and local anesthetics alone or with hydrodilatation-corticosteroid and local anesthetics plus sterile saline solution) and then they will follow a rehabilitation program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frozen Shoulder Shoulder Capsulitis Shoulder Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two-arm study with one hydrodilatation group compared with the standart treatment group(cortisteroid injection)
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrasound Guided Hydrodilatation with corticosteroid injection

15 ml intra-articular injection to shoulder via anterior approach under ultrasound guidance

Drugs:

* betamethasone dipropionate/ betamethasone sodium phosphate(diprospan) (5 mg+2mg/ml) (1 ml)
* prilocaine hydrochloride %2 (4 ml)
* Sodium chloride %0,9 (10 ml)

Group Type EXPERIMENTAL

Ultrasound Guided Hydrodilatation with corticosteroid injection

Intervention Type OTHER

15 ml intra-articular injection to shoulder via anterior approach under ultrasound guidance

Blind intra-articular corticosteroid injection

5 ml intra-articular blind injection to shoulder via posterior approach

Drugs:

* betamethasone dipropionate/ betamethasone sodium phosphate(diprospan) (5 mg+2mg/ml) (1 ml)
* prilocaine hydrochloride %2 (4 ml)

Group Type ACTIVE_COMPARATOR

Intra-articular corticosteroid injection

Intervention Type OTHER

5 ml blind intra-articular corticosteroid injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intra-articular corticosteroid injection

5 ml blind intra-articular corticosteroid injection

Intervention Type OTHER

Ultrasound Guided Hydrodilatation with corticosteroid injection

15 ml intra-articular injection to shoulder via anterior approach under ultrasound guidance

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who fulfill the diagnostic criteria for frozen shoulder
* Agree to participate in the study
* Having the opportunity to follow up for at least 3 months

Exclusion Criteria

* Refusing to participate in the study
* History of shoulder injection in the last 3 months
* Having diabetes mellitus
* Presence of comorbidities that contraindicate injection therapy, such as bleeding diathesis
* Known history of allergy or anaphylaxis to drugs used in treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fatmanur Yegin

Research Assistant Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fatmanur Yegin

Role: CONTACT

0905462729955

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/890

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.